Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-10 (Tenovil) in the prevention of post-ERCP acute pancreatitis
NCT00040131Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jan 2002
- Primary completion
- Dec 2002
01
Overview
A Phase 2 trial of interleukin 10 in acute pancreatitis (AP), sponsored by Merck & Co.. Started Jan 2002; status: terminated.
02
Drugs
interleukin 10
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT00040131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040131.